The effects of cholesterol on learning and memory
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Cholesterol is vital to normal brain function including learning and memory but that involvement is as complex as the synthesis, metabolism and excretion of cholesterol itself. Dietary cholesterol influences learning tasks from water maze to fear conditioning even though cholesterol does not cross the blood brain barrier. Excess cholesterol has many consequences including peripheral pathology that can signal brain via cholesterol metabolites, proinflammatory mediators and antioxidant processes. Manipulations of cholesterol within the central nervous system through genetic, pharmacological, or metabolic means circumvent the blood brain barrier and affect learning and memory but often in animals already otherwise compromised. The human literature is no less complex. Cholesterol reduction using statins improves memory in some cases but not others. There is also controversy over statin use to alleviate memory problems in Alzheimer’s disease. Correlations of cholesterol and cognitive function are mixed and association studies find some genetic polymorphisms are related to cognitive function but others are not. In sum, the field is in flux with a number of seemingly contradictory results and many complexities. Nevertheless, understanding cholesterol effects on learning and memory is too important to ignore.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“…and transgenic rodents, indicates it is the oligomeric form of beta amyloid that is important for its toxic effects and its effects on learning and memory (Billings et al., 2005; Billings et al., 2007; Dineley et al., 2002; Lesne et al., 2006; Ma et al., 2007; Morgan, 2003; Shankar et al., 2008).”
BackgroundRetractedDevelopments of a water-maze procedure for studying spatial learning in the rat
Morris, R. (1984) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(84)90007-4 · Cited by 7,180 · cited 1×
“Water maze The water maze is a spatial navigation task also known as the Morris water maze (Morris, 1984) that assesses spatial learning and memory by allowing a mouse or rat to swim in a pool of opaque water in which an escape platform has been placed.”
MethodSoluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 1×
“The initial debate about the relative effects of soluble versus insoluble beta amyloid (Despande et al., 2006; Gouras et al., 2005; Haass and Selkoe, 2007; Kayed et al., 2003; Zerbinatti et al., 2004) has given way to a more recent discussion of the oligomeric form of beta amyloid with Neurosci…”
BackgroundCommon structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Intracellular amyloid-β in Alzheimer's disease
LaFerla, F. M., Green, K. N., & Oddo, S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2168 · Cited by 1,942
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938 · cited 1×
“…Author M anuscript N IH -PA Author M anuscript higher soluble oligomers being more toxic and having greater effects on synaptic plasticity than monomers or dimers (Chafekar et al., 2008; Lacor et al., 2007; LaFerla et al., 2007; Shankar et al., 2007; Shankar et al., 2008; Walsh and Selkoe, 2007).”
BackgroundThe role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661 · cited 2×
“In a recent review, Kim et al. (2009) describe additional roles for ApoE including involvement in neurotoxicity, tau phosphorylation, neuroinflammation, cerebrovascular function and brain metabolism.”
BackgroundShankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592 · cited 1×
“…Author M anuscript N IH -PA Author M anuscript higher soluble oligomers being more toxic and having greater effects on synaptic plasticity than monomers or dimers (Chafekar et al., 2008; Lacor et al., 2007; LaFerla et al., 2007; Shankar et al., 2007; Shankar et al., 2008; Walsh and Selkoe, 2007).”
Background
Research works printed but not linked: 187
- Arndt, 2001, Methods for behavioural phenotyping of mouse mutants. How to keep the overview, Behav. Brain Res., 125, 39, 10.1016/S0166-4328(01)00285-6 · doi:10.1016/s0166-4328(01)00285-6
- Arvanitakis, 2008, Statins, incident Alzheimer disease, change in cognitive function, and neuropathology, Neurology, 70, 1795, 10.1212/01.wnl.0000288181.00826.63 · DOI · Paper page
- Atzmon, 2002, Plasma HDL levels highly correlate with cognitive function in exceptional longevity, J. Gerontol. Ser. A Biol. Sci. Med. Sci., 57A, M712, 10.1093/gerona/57.11.M712 · DOI · Paper page
- Bahia, 2008, Polymorphisms of APOE and LRP genes in Brazilian individuals with Alzheimer disease, Alzheimer's Dis. Assoc. Disord., 22, 61, 10.1097/WAD.0b013e31815a9da7 · DOI
- Baldwin, 2009, Neuropsychological assessment in the diagnosis of Alzheimer's disease, Curr. Protocols Neurosci., 49, 1031, 10.1002/0471142301.ns1003s49 · DOI
- Bales, K.R. Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease. Neuropharmacology, in press.
- Baranowski, 2008, Biological role of liver X receptors, J. Physiol. Pharmacol., 59, 31
- Beach, 2008, Physiologic origins of age-related β-amyloid deposition, Neurodegenerative Dis., 5, 143, 10.1159/000113685 · DOI
- Bernick, 2005, Statins and cognitive function in the elderly, Neurology, 65, 1388, 10.1212/01.wnl.0000182897.18229.ec · DOI · Paper page
- Bertram, 2007, The LDLR locus in Alzheimer's disease: a family-based study and meta-analysis of case-control data, Neurobiol. Aging, 18, e18
- Billings, 2007, Learning decreases Aβ*56 and tau pathology and ameliorates behavioral decline in 3xTg-AD mice, J. Neurosci., 27, 751, 10.1523/JNEUROSCI.4800-06.2007 · DOI · Paper page
- Bjorkhem, 2002, Do oxysterols control cholesterol homeostasis?, J. Clin. Invest., 110, 725, 10.1172/JCI0216388 · doi:10.1172/jci0216388 · Paper page
- Bjorkhem, 2009, Are side-chain oxidized oxysterols regulators also in vivo?, J. Lipid Res., 50, S213, 10.1194/jlr.R800025-JLR200 · DOI · Paper page
- Bjorkhem, 2009, Oxysterols and neurodegenerative disorders, Mol. Aspects Med., 30, 171, 10.1016/j.mam.2009.02.001 · DOI · Paper page
- Bour, 2008, Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks, Behav. Brain Res., 193, 174, 10.1016/j.bbr.2008.05.008 · DOI · Paper page
- Brooks, 2004, Behavioural profiles of inbred mouse strains used as transgenic backgrounds. I: motor tests, Genes Brain Behav., 3, 206, 10.1111/j.1601-183X.2004.00072.x · DOI · Paper page
- Brouwers, 2008, Molecular genetics of Alzheimer's disease: an update, Ann. Med., 18, 1
- Burgess, 2008, ABCG1 influences the brain cholesterol biosynthetic pathway but does not affect amyloid precursor protein or apolipoprotein E metabolism in vivo, J. Lipid Res., 49, 1254, 10.1194/jlr.M700481-JLR200 · DOI · Paper page
- Canevari, 2007, Alzheimer's disease and cholesterol: the fat connection, Neurochem. Res., 32, 739, 10.1007/s11064-006-9200-1 · DOI
- Carlsson, 2008, Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer's disease, J. Alzheimer's Dis., 13, 187, 10.3233/JAD-2008-13209 · DOI · Paper page
- Carlsson, 2009, increased atherogenic lipoproteins are associated with cognitive impairment: effects of statins and subclinical atherosclerosis, Alzheimer's Dis. Assoc. Disord., 23, 11, 10.1097/WAD.0b013e3181850188 · DOI · Paper page
- Chafekar, 2008, Oligomer-specific aβ toxicity in cell models is mediated by selective uptake, Biochim. Biophys. Acta, 1782, 523, 10.1016/j.bbadis.2008.06.003 · DOI
- Chen, 2002, Learning and recall in subjects at genetic risk for Alzheimer's disease, J. Neuropsych. Clin. Neurosci., 14, 58, 10.1176/jnp.14.1.58 · DOI
- Chen, 2008, Caffeine blocks disruption of the blood brain barrier in a rabbit model of Alzheimer's disease, J. Neuroinflamm., 5, 1, 10.1186/1742-2094-5-12 · DOI · Paper page
- Darwish, 2010, Dietary cholesterol impairs memory and memory increases brain cholesterol and sulfatide levels, Behav. Neurosci., 124, 115, 10.1037/a0018253 · DOI
- de Frias, 2007, Cholesterol and triglycerides moderate the effect of apolipoprotein E on memory functioning in older adults, J. Gerentol. Psychol. Sci., 62B, P112, 10.1093/geronb/62.2.P112 · DOI · Paper page
- Deane, 2009, Clearance of amyloid-β across the blood-brain barrier: implications for therapies in Alzheimer's disease, CNS Neurol. Disord. Drug Targets, 8, 16, 10.2174/187152709787601867 · DOI · Paper page
- Deary, 2002, Cognitive change and the APOE ɛ4 allele, Nature, 418, 932, 10.1038/418932a · DOI · Paper page
- Despande, 2006, Different conformations of amyloid β induce toxicity by distinct mechanisms in human cortical neurons, J. Neurosci., 26, 6011, 10.1523/JNEUROSCI.1189-06.2006 · DOI · Paper page
- Deyo, 1989, Nimodipine facilitates associative learning in aging rabbits, Science, 243, 809, 10.1126/science.2916127 · DOI · Paper page
- Di Filippo, 2008, Neuroinflammation and synaptic plasticity: theoretical basis for a movel, immune-centred, therapeutic approach to neurological disorders, Trends Pharmacol. Sci., 29, 402, 10.1016/j.tips.2008.06.005 · DOI · Paper page
- Dik, 2001, Memory complaints and APOE-ɛ4 accelerate cognitive decline in cognitively normal elderly, Neurology, 57, 2217, 10.1212/WNL.57.12.2217 · DOI · Paper page
- Dufour, 2006, Cholesterol-enriched diet affects spatial learning and synaptic function in hippocampal synapses, Brain Res., 1103, 88, 10.1016/j.brainres.2006.05.086 · DOI
- Eddins, 2009, Hippocampal infusion of apolipoprotein E peptides induce long-lasting cognitive impairment, Brain Res. Bull., 79, 111, 10.1016/j.brainresbull.2009.01.003 · DOI
- Elder, 2007, Elevated plasma cholesterol does not affect brain Aβ in mice lacking the low-density lipoprotein receptor, J. Neurochem., 102, 1220, 10.1111/j.1471-4159.2007.04614.x · DOI · Paper page
- Elias, 2005, Serum cholesterol and cognitive performance in the Framingham heart study, Psychosom. Med., 67, 24, 10.1097/01.psy.0000151745.67285.c2 · DOI · Paper page
- Endo, 1996, Impairment of maze learning in rats following long-term glucocorticoid treatments, Neurosci. Lett., 203, 199, 10.1016/0304-3940(95)12296-6 · DOI
- Esler, 2002, Apolipoprotein E affects amyloid formation but not amyloid growth in vitro: mechanistic implications for ApoE4 enhanced amyloid burden and risk for Alzheimer's disease, Amyloid: J. Protein Folding Disord., 9, 1, 10.3109/13506120209072439 · DOI
- Evans, 2009, Statin-associated adverse cognitive effects: survey results from 171 patients, Pharmacotherapy, 29, 800, 10.1592/phco.29.7.800 · DOI · Paper page
- Evans, 2000, Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans, Neurology, 54, 240, 10.1212/WNL.54.1.240 · DOI · Paper page
- Fassbender, 2002, Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide, Neurology, 59, 1257, 10.1212/WNL.59.8.1257 · DOI · Paper page
- Fernandez del Pozo, 2006, Polymorphism in the cholesterol 24S-hydroxylase gene (CYP46A1) associated with the APOEpsilon3 allele increases the risk of Alzheimer's disease and of mild cognitive impairment progressing to Alzheimer's disease, Dement. Geriatr. Cogn. Disord., 21, 81, 10.1159/000090215 · DOI
- Flory, 2000, Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults, Am. J. Med. Genet. (Neuropsych. Genet.), 96, 707, 10.1002/1096-8628(20001204)96:6<707::AID-AJMG1>3.0.CO;2-V · DOI · Paper page
- Foster, 2006, Biological markers of age-related memory deficits. Treatment of senescent physiology, CNS Drugs, 20, 153, 10.2165/00023210-200620020-00006 · DOI
- Frears, 1999, The role of cholesterol in the biosynthesis of β-amyloid, NeuroReport, 10, 1699, 10.1097/00001756-199906030-00014 · DOI · Paper page
- Fu, 2009, Cholesterol 24-hydroxylase (CYP46A1) polymorphisms are associated with faster cognitive deterioration in Chinese older persons: a two-year follow up study, Int. J. Geriatr. Psychiatry, 24, 921, 10.1002/gps.2196 · DOI
- Ghribi, 2006, Deposition of iron and β-amyloid plaques is associated with cortical cellular damage in rabbits fed with long-term cholesterol-enriched diets, J. Neurochem., 99, 438, 10.1111/j.1471-4159.2006.04079.x · DOI · Paper page
- Ghribi, 2006, High cholesterol content in neurons increases BACE, β-amyloid, and phosphorylated tau levels in rabbit hippocampus, Exp. Neurol., 200, 460, 10.1016/j.expneurol.2006.03.019 · DOI · Paper page
- Gotto, 2001, Pleiotropic effects of statins: do they matter?, Curr. Opin. Lipidol., 12, 391, 10.1097/00041433-200108000-00004 · DOI · Paper page
- Granholm, 2008, Effects of a saturated fat and high cholesterol diet on memory and hippocampal morphology in middle-aged rats, J. Alzheimer's Dis., 14, 133, 10.3233/JAD-2008-14202 · DOI · Paper page
- Grimm, 2007, Amyloid beta as a regulator of lipid homeostasis, Trends Mol. Med., 13, 337, 10.1016/j.molmed.2007.06.004 · DOI
- Hansson, 2008, Inflammation and atherosclerosis, Ann. Rev. Pathol. Mech. Dis., 1, 297, 10.1146/annurev.pathol.1.110304.100100 · DOI · Paper page
- Harris-White, 2004, Role of LRP in TGFbeta2-mediated neuronal uptake of Abeta and effects on memory, J. Neurosci. Res., 77, 217, 10.1002/jnr.20149 · DOI · Paper page
- Hartmann, 1994, Apolipoprotein E and cholesterol affect neuronal calcium signalling: the possible relationship to β-neurotoxicity, Biochem. Biophys. Res. Commun., 200, 1185, 10.1006/bbrc.1994.1576 · DOI
- Hartmann, 2001, Cholesterol, Aβ and Alzheimer's disease, Trends Neurosci., 11, S45, 10.1016/S0166-2236(00)01990-1 · DOI
- Hartmann, 2006, Role of amyloid precursor protein, amyloid-β and γ-secretase in cholesterol maintenance, Neurodegenerative Dis., 3, 305, 10.1159/000095271 · DOI
- Heverin, 2005, Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain, J. Lipid Res., 46, 1047, 10.1194/jlr.M500024-JLR200 · DOI · Paper page
- Hoglund, 2005, The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease, Dement. Geriatr. Cogn. Disord., 19, 256, 10.1159/000084550 · DOI · Paper page
- Hoshino, 2002, Gene dose effect of the APOE-ɛ4 allele on plasma HDL cholesterol level in patients with Alzheimer's disease, Neurobiol. Aging, 23, 41, 10.1016/S0197-4580(01)00252-4 · DOI
- Hoyer, 2007, Alzheimer disease - no traget for statin treatment. A mini review, Neurochem. Res., 32, 695, 10.1007/s11064-006-9168-x · DOI
- Hudry, 2009, Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after onset of amyloid plaques in mouse models of Alzheimer's disease, Mol. Therapy, 18, 44, 10.1038/mt.2009.175 · DOI · Paper page
- Jacova, 2007, Neuropsychological testing and assessment of dementia, Alzheimer's Dementia, 3, 299, 10.1016/j.jalz.2007.07.011 · DOI · Paper page
- Jaeger, 2010, Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition, J. Alzheimer's Dis., 17, 553, 10.3233/JAD-2009-1074 · DOI · Paper page
- Jarvik, 1995, Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease, Neurology, 45, 1092, 10.1212/WNL.45.6.1092 · DOI · Paper page
- Jasinska, 2007, Statins: a new insight into their mechanisms of action and consequent pleiotropic effects, Pharmacol. Rep., 59, 483
- Jaya Prasanthi, 2008, Regulation of β-amyloid levels in the brain of cholesterol-fed rabbit, a model system for sporadic Alzheimer's disease, Mech. Ageing Dev., 29, 649, 10.1016/j.mad.2008.09.002 · DOI · Paper page
- Jessup, 2004, Lipid peroxidation in atherogenesis: an overview, Biochem. Soc. Trans., 32, 134, 10.1042/bst0320134 · DOI
- Jick, 2000, Statins and the risk of dementia, Lancet, 356, 1627, 10.1016/S0140-6736(00)03155-X · DOI · Paper page
- Joseph, 2001, Copernicus revisited: amyloid beta in Alzheimer's disease, Neurobiol. Aging, 22, 131, 10.1016/S0197-4580(00)00211-6 · DOI · Paper page
- Juva, 2000, Apolipoprotein E, cognitive function, and dementia in a general population aged 85 years and over, Int. Psychogeriatr., 12, 379, 10.1017/S1041610200006487 · DOI
- Kainuma, 2006, Cholesterol-fed rabbit as a unique model of nonalcoholic, nonobese, non-insulin-resistant fatty liver disease with characteristic fibrosis, J. Gastroenterol., 41, 971, 10.1007/s00535-006-1883-1 · DOI
- Kane, 1999, Effect of chronic nimodipine on spatial learning and on long-term potentiation, Behav. Brain Res., 98, 95, 10.1016/S0166-4328(98)00057-6 · DOI
- Kessler, 1986, In vivo modulation of brain cholesterol level and learning performance by a novel plant lipid: indication of interactions between hippocampal-cortical cholesterol and learning, Life Sci., 38, 1185, 10.1016/0024-3205(86)90173-6 · DOI
- Kim, 2002, Apolipoprotein E ɛ4 Allele is not associated with the cognitive impairment in community-dwelling normal elderly individuals, Int. J. Geriatr. Psychiatry, 17, 635, 10.1002/gps.664 · DOI
- Kim, 2008, Role of ATP-binding cassette transporters in brain lipid transport and neurological disease, J. Neurochem., 104, 1145, 10.1111/j.1471-4159.2007.05099.x · DOI · Paper page
- Kirsch, 2003, Brain cholesterol, statins and Alzheimer's disease, Pharmacopsychiatry, 36, S113, 10.1055/s-2003-43058 · DOI · Paper page
- Koladiya, 2008, Ameliorative role of atorvastatin and pitavastatin in L-methionine induced vascular dementia in rats, BMC Pharmacol., 9, 8
- Kolsch, 2004, Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients, Neurosci. Lett., 368, 303, 10.1016/j.neulet.2004.07.031 · DOI
- Kotti, 2006, Brain cholesterol turnover required for geranylgeraniol production and learning in mice, Proc. Natl. Acad. Sci. U.S.A., 103, 3869, 10.1073/pnas.0600316103 · DOI · Paper page
- Koudinov, 2001, Essential role of cholesterol in synaptic plasticity and neuronal degeneration, FASEB J., 15, 1858, 10.1096/fj.00-0815fje · DOI · Paper page
- Ledesma, 2006, Amyloid excess in Alzheimer's disease: what is cholesterol to be blamed for?, FEBS Lett., 580, 5525, 10.1016/j.febslet.2006.06.038 · DOI · Paper page
- Lefterov, I., Fitz, N.F., Cronican, A., Lefterov, P., Staufenbiel, M., Koldamova, R., 2009. Memory deficits in APP23/Abca1+/- mice correlate with the level of Abeta oligomers. ASN Neuro 1. · DOI · Paper page
- Lesser, 2009, Serum lipid levels are related to Alzheimer's pathology in nursing home residents, Dement. Geriatr. Cogn. Disord., 27, 42, 10.1159/000189268 · DOI
- Li, 2003, Association of aortic atherosclerosis with cerebral β-amyloidosis and learning deficits in a mouse model of Alzheimer's disease, Am. J. Pathol., 163, 2155, 10.1016/S0002-9440(10)63572-9 · DOI · Paper page
- Li, 2006, Simvastatin enhances learning and memory independent of amyloid load in mice, Ann. Neurol., 60, 729, 10.1002/ana.21053 · DOI · Paper page
- Liu, 1998, Amyloid β peptide alters intracellular vesicle trafficking and cholesterol homeostasis, Proc. Natl. Acad. Sci. U.S.A., 95, 13266, 10.1073/pnas.95.22.13266 · DOI · Paper page
- Lominska, 2001, Apolipoprotein E deficiency effects on learning in mice are dependent upon the background strain, Behav. Brain Res., 120, 23, 10.1016/S0166-4328(00)00365-X · DOI
- Lu, 2007, Statins increase neurogenesis in the dentate gyrus, reduce delayed neuronal death in the hippocampal CA3 region, and improve spatial learning in rat after traumatic brain injury, J. Neurotrauma, 24, 1132, 10.1089/neu.2007.0288 · DOI · Paper page
- Lu, 2009, Trace amounts of copper exacerbate beta amyloid-induced neurotoxicity in the cholesterol-fed mice through TNF-mediated inflammatory pathway, Brain Behav. Immun., 23, 193, 10.1016/j.bbi.2008.09.003 · DOI
- Ma, 2007, Involvment of β-site APP cleaving emzyme 1 (BACE1) in amyloid precusor protein-mediated enhancement of memory and activity-dependent synaptic plasticity, Proc. Natl. Acad. Sci., 104, 8167, 10.1073/pnas.0609521104 · DOI · Paper page
- Mahfouz, 2000, Cholesterol-rich diets have different effects on lipid peroxidation, cholesterol oxides, and antioxidant enzymes in rats and rabbits, J. Nutr. Biochem., 11, 293, 10.1016/S0955-2863(00)00083-8 · DOI
- Martins, 2009, Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease, J. Neurochem., 111, 1275, 10.1111/j.1471-4159.2009.06408.x · DOI · Paper page
- Masse, 2005, Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease, J. Neurol. Neurosurg. Psych., 76, 1624, 10.1136/jnnp.2005.063388 · DOI · Paper page
- Mayeux, 2001, Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E, Neurobiol. Aging, 22, 683, 10.1016/S0197-4580(01)00223-8 · DOI
- McLaurin, 2003, Cholesterol, a modulator of membrane-associated aβ-fibrillogenesis, Pharmacopsychiatry, 36, S130, 10.1055/s-2003-43054 · DOI
- Micale, 2008, Behavioral effects of dietary cholesterol in rats tested in experimental models of mild stress and cognition tasks, Eur. Neuropsychopharmacol., 18, 462, 10.1016/j.euroneuro.2007.11.006 · DOI
- Miller, 1994, Cholesterol treatment facilitates spatial learning performance in DBA/2Ibg mice, Pharmacol. Biochem. Behav., 49, 257, 10.1016/0091-3057(94)90487-1 · DOI
- Morgan, 2003, Learning and memory deficits in APP transgenic mouse models of amyloid deposition, Neurochem. Res., 28, 1029, 10.1023/A:1023255106106 · DOI
- Muldoon, 2000, Effects of lovastatin on cognitive function and psychological well-being, Am. J. Med., 108, 538, 10.1016/S0002-9343(00)00353-3 · DOI · Paper page
- Muldoon, 1997, Serum cholesterol and intellectual performance, Psychosom. Med., 59, 382, 10.1097/00006842-199707000-00008 · DOI · Paper page
- Nayler, 1999, Review of preclinical data of calcium channel blockers and atherosclerosis, J. Cardiovasc. Pharmacol., 33, 10.1097/00005344-199900002-00003 · DOI
- Notkola, 1998, Serum total cholesterol, apolipoprotein Eɛ4 allele, and Alzheimer's disease, Neuroepidemiology, 17, 14, 10.1159/000026149 · DOI · Paper page
- O’Brien, 2002, Developmental sensitivity of associative learning to cholesterol synthesis inhibitors, Behav. Brain Res., 129, 141, 10.1016/S0166-4328(01)00342-4 · DOI
- Obrenovich, 2002, Amyloid-β: a (life) preserver for the brain, Neurobiol. Aging, 23, 1097, 10.1016/S0197-4580(02)00038-6 · DOI
- Panza, 2006, Lipid metabolism in cognitive decline and dementia, Brain Res. Rev., 51, 275, 10.1016/j.brainresrev.2005.11.007 · DOI · Paper page
- Papassotiropoulos, 2002, 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia, J. Psychiatr. Res., 36, 27, 10.1016/S0022-3956(01)00050-4 · DOI · Paper page
- Papassotiropoulos, 2005, A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease, J. Clin. Psychiatry, 66, 940, 10.4088/JCP.v66n0720 · DOI · Paper page
- Parale, 2006, Effects of atorvastatin on higher functions, Eur. J. Clin. Pharmacol., 62, 259, 10.1007/s00228-005-0073-z · DOI
- Parkinson, P.F., Kannangara, T.S., Eadie, B.D., Burgess, B.L., Wellington, C.L., Christie, B.R., 2009. Cognition, learning behaviour and hippocampal synaptic plasticity are not disrupted in mice over-expressing the cholesterol transporter ABCG1. Lipids in Health and Disease 8. · DOI
- Perry, 2009, No association between cognitive acheivements, academic performance and serum cholesterol concentrations among school-aged children, Nutr. Neurosci., 12, 160, 10.1179/147683009X423328 · DOI
- Pickering, 2007, Pro-inflammatory cytokines and their effects in the dentate gyrus, Prog. Brain Res., 163, 339, 10.1016/S0079-6123(07)63020-9 · DOI · Paper page
- Poirier, 2005, Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease, Neurobiol. Aging, 26, 355, 10.1016/j.neurobiolaging.2004.09.003 · DOI · Paper page
- Qiu, 2006, A fresh look at an ancient family: emerging roles for low density lipoprotein receptors in synaptic plasticity and memory formation, Neurobiol. Learn. Mem., 85, 16, 10.1016/j.nlm.2005.08.009 · DOI
- Quartermain, 2000, Chronic administration of the Ca2+ channel blocker amlodipine facilitates learning and memory in mice, Eur. J. Pharmacol., 399, 57, 10.1016/S0014-2999(00)00368-X · DOI
- Quartermain, 2001, Calcium channel antagonists enhance retention of passive avoidance and maze learning in mice, Neurobiol. Learn. Mem., 75, 77, 10.1006/nlme.1999.3958 · DOI
- Raffai, 2003, Cholesterol: from heart attacks to Alzheimer's disease, J. Lipid Res., 44, 1423, 10.1194/jlr.R300007-JLR200 · DOI · Paper page
- Rafnsson, 2009, Peripheral arterial disease and cognitive function, Vasc. Med., 14, 51, 10.1177/1358863X08095027 · DOI
- Reid, 2007, Alzheimer's disease: cholesterol, membrane rafts, isoprenoids and statins, J. Cell. Mol. Med., 11, 383, 10.1111/j.1582-4934.2007.00054.x · DOI · Paper page
- Reitan, 1963, The relationship of serum cholesterol changes to psychological abilities, J. Gerontol., 18, 350, 10.1093/geronj/18.4.350 · doi:10.1093/geronj/18.4.350
- Reynolds, 2009, A survey of ABCA1 sequence variation confirms association with dementia, Hum. Mutat., 30, 1, 10.1002/humu.21076 · DOI · Paper page
- Reynolds, 2006, Longitudinal memory performance during normal aging: twin association models of APOE and other Alzheimer candidate genes, Behav. Genet., 36, 185, 10.1007/s10519-005-9027-6 · DOI
- Robinson, 2002, Aβ as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease, Neurobiol. Aging, 23, 1051, 10.1016/S0197-4580(01)00342-6 · DOI
- Roher, 1999, Amyloid and lipids in the pathology of Alzheimer disease, Amyloid: J. Protein Folding Dis., 6, 136, 10.3109/13506129909007315 · DOI · Paper page
- Romero, 2009, Carotid artery atherosclerosis. MRI indices of brain ischemia, aging, and cognitive impairment: the Framingham study, Stroke, 40, 1590, 10.1161/STROKEAHA.108.535245 · DOI · Paper page
- Ronald, 2009, Clinical field-strength MRI of amyloid plaques induced by low-level cholesterol feeding in rabbits, Brain, 132, 1346, 10.1093/brain/awp031 · DOI
- Sagare, 2007, Clearance of amyloid-β by circulating lipoprotein receptors, Nat. Med., 13, 1029, 10.1038/nm1635 · DOI · Paper page
- Salo, 2002, Does apolipoprotein E influence learning and memory in the nondemented oldest old?, Int. Psychogeriatr., 13, 451, 10.1017/S1041610201007864 · DOI · Paper page
- Savory, 2002, Is amyloid β-peptide neurotoxic or neuroprotective and what is its role in the binding of metal ions?, Neurobiol. Aging, 23, 1089, 10.1016/S0197-4580(02)00037-4 · DOI
- Schachter, 1997, Calcium antagonists and atherosclerosis, Int. J. Cardiol., 62, S9, 10.1016/S0167-5273(97)00236-2 · doi:10.1016/s0167-5273(97)00236-2
- Schafers, 2008, Effects of cytokines on neuronal excitability, Neurosci. Lett., 437, 188, 10.1016/j.neulet.2008.03.052 · DOI · Paper page
- Schmajuk, 1990, Eyeblink conditioning in rats, Physiol. Behav., 48, 755, 10.1016/0031-9384(90)90221-O · doi:10.1016/0031-9384(90)90221-o
- Schreurs, 2007, Classical conditioning of the rabbit's nictitating membrane response is a function of the duration of dietary cholesterol, Nutr. Neurosci., 10, 159, 10.1080/10284150701565540 · DOI
- Schreurs, 2007, High dietary cholesterol facilitates classical conditioning of the rabbit's nictitating membrane response, Nutr. Neurosci., 10, 31, 10.1080/10284150701232034 · DOI
- Schreurs, 2007, Cholesterol enhances classical conditioning of the rabbit heart rate response, Behav. Brain Res., 181, 52, 10.1016/j.bbr.2007.03.024 · DOI
- Schreurs, 2003, Cholesterol modifies classical conditioning of the rabbit (Oryctolagus cuniculus) nictitating membrane response, Behav. Neurosci., 117, 1220, 10.1037/0735-7044.117.6.1220 · DOI
- Servatius, 2003, Facilitated acquisition of the classically conditioned eyeblink response in male rats after systemic IL-1β, Integr. Physiol. Behav. Sci., 38, 169, 10.1007/BF02688851 · DOI
- Sharma, 2008, Hypercholesterolemia-induced Aβ accumulation in rabbit brain is associated with alteration in IGF-1 signaling, Neurobiol. Dis., 32, 426, 10.1016/j.nbd.2008.08.002 · DOI · Paper page
- Simons, 2001, Cholesterol and Alzheimer's disease: Is there a link?, Neurology, 57, 1089, 10.1212/WNL.57.6.1089 · DOI · Paper page
- Singh-Manoux, 2008, Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study, Arteriosclerosis, Thrombosis Vasc. Biol., 28, 1556, 10.1161/ATVBAHA.108.163998 · DOI · Paper page
- Sjogren, 2006, Cholesterol and Alzheimer's disease—Is there a relation?, Mech. Ageing Dev., 127, 138, 10.1016/j.mad.2005.09.020 · DOI
- Skelton, 1988, Bilateral cerebellar lesions disrupt conditioned eyelid responses in unrestrained rats, Behav. Neurosci., 102, 586, 10.1037/0735-7044.102.4.586 · doi:10.1037/0735-7044.102.4.586
- Small, 2000, Is ApoE-ɛ4 a risk factor for cognitive impairment in normal aging?, Neurology, 54, 2082, 10.1212/WNL.54.11.2082 · DOI · Paper page
- Solomon, 2007, Serum cholesterol changes after midlife and late-life cognition, Neurology, 68, 751, 10.1212/01.wnl.0000256368.57375.b7 · DOI · Paper page
- Solomon, 2009, Cholesterol-modifying strategies for Alzheimer's disease, Expert Rev. Neurotherap., 9, 695, 10.1586/ern.09.25 · DOI · Paper page
- Sparks, 1997, Coronary artery disease, hypertension, ApoE and cholesterol: a link to Alzheimer's disease, Ann. N. Y. Acad. Sci., 826, 128, 10.1111/j.1749-6632.1997.tb48466.x · DOI · Paper page
- Sparks, 2004, Cholesterol, copper, and accumulation of thioflavine s-reactive Alzheimer's-like amyloid β in rabbit brain, J. Mol. Neurosci., 24, 97, 10.1385/JMN:24:1:097 · DOI
- Sparks, 2007, Cholesterol metabolism and brain amyloidosis: evidence for a role of copper in the clearance of Aβ through the liver, Curr. Alzheimer Res., 4, 165, 10.2174/156720507780362119 · DOI
- Sparks, 2002, HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advised to use one that crosses the blood-brain barrier, J. Nutr. Health Aging, 6, 324
- Sparks, 2006, Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial, Acta Neurol. Scand., 114, s3, 10.1111/j.1600-0404.2006.00690.x · DOI · Paper page
- Sparks, 2008, Reduced risk of incident AD with elective statin use in a clinical trial cohort, Curr. Alzheimer Res., 5, 416, 10.2174/156720508785132316 · DOI · Paper page
- Sparks, 2000, Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation. Preliminary observations, Ann. N. Y. Acad. Sci., 903, 335, 10.1111/j.1749-6632.2000.tb06384.x · DOI · Paper page
- Sparks, 2002, Water quality has a pronounced effect on cholesterol-induced accumulation of Alzheimer amyloid (aβ) in rabbit brain, J. Alzheimer's Dis., 4, 523, 10.3233/JAD-2002-4609 · DOI
- Sparks, 2007, Influence of water quality on cholesterol induced systemic pathology, J. Nutr. Health Aging, 11, 189
- Sparks, 1994, Induction of Alzheimer-like β-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol, Exp. Neurol., 126, 88, 10.1006/exnr.1994.1044 · DOI · Paper page
- Sparks, 2003, Trace amounts of copper in water induce β-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease, Proc. Natl. Acad. Sci. U.S.A., 100, 11065, 10.1073/pnas.1832769100 · DOI · Paper page
- Stewart, 2001, Apolipoprotein E genotype, vascular risk and early cognitive impairment in an African Caribbean population, Dement. Geriatr. Cogn. Disord., 12, 251, 10.1159/000051267 · DOI
- Teunissen, 2003, Serum cholesterol, precursors and metabolites and cognitive performance in an aging population, Neurobiol. Aging, 24, 147, 10.1016/S0197-4580(02)00061-1 · DOI
- Thelen, 2006, High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels, J. Clin. Pharmacol., 46, 812, 10.1177/0091270006289851 · DOI · Paper page
- Thirumangalakudi, 2008, High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with the loss of working memory in mice, J. Neurochem., 106, 475, 10.1111/j.1471-4159.2008.05415.x · DOI · Paper page
- Upchurch, 1988, DBA/2Ibg mice are incapable of cholinergically-based learning in the Morris water maze, Pharmacol. Biochem. Behav., 29, 325, 10.1016/0091-3057(88)90164-5 · DOI
- van den Kommer, 2009, Total cholesterol and oxysterols: early markers for cognitive decline in elderly?, Neurobiol. Aging, 30, 534, 10.1016/j.neurobiolaging.2007.08.005 · DOI
- van der Staay, 2001, Behavioral phenotyping of mouse mutants, Behav. Brain Res., 125, 3, 10.1016/S0166-4328(01)00278-9 · DOI
- van Exel, 2002, Association between high-density lipoprotein and cognitive impairment in the oldest old, Ann. Neurol., 51, 716, 10.1002/ana.10220 · DOI · Paper page
- Veinbergs, 2002, Neurotoxic effects of apolipoprotein E4 are mediated via dysregulation of calcium homeostasis, J. Neurosci. Res., 67, 379, 10.1002/jnr.10138 · DOI · Paper page
- Veinbergs, 2000, Vitamin E supplementation prevents spatial learning deficits and dendritic alterations in aged apolipoprotein E-deficient mice, Eur. J. Neurosci., 12, 4541
- Viviani, 2007, Cytokines and neuronal ion channels in health and disease, Int. Rev. Neurobiol., 82, 247, 10.1016/S0074-7742(07)82013-7 · DOI · Paper page
- Voikar, 2002, Cognitive deficit and development of motor impairment in a mouse model of Niemann-Pick type C disease, Behav. Brain Res., 132, 1, 10.1016/S0166-4328(01)00380-1 · DOI
- Wahrle, 2002, Cholesterol-dependent γ-secretase activity in buoyant cholesterol-rich membrane microdomains, Neurobiol. Dis., 9, 11, 10.1006/nbdi.2001.0470 · DOI · Paper page
- Wegiel, 2007, Intraneuronal Aβ immunoreactivity is not a predictor of brain amyloidosis-β or neurofibrillary degeneration, Acta Neuropathol. (Berl.), 113, 389, 10.1007/s00401-006-0191-4 · DOI · Paper page
- West, 2008, Better memory functioning associated with higher total and low-density lipoprotein cholesterol levels in very elderly subjects without the apolipoprotein e4 allele, Am. J. Geriatr. Psychiatry, 16, 781, 10.1097/JGP.0b013e3181812790 · DOI · Paper page
- Wilson, 2002, The apolipoprotein E ɛ4 allele and decline in different cognitive systems during a 6-year period, Arch. Neurol., 59, 1154, 10.1001/archneur.59.7.1154 · DOI · Paper page
- Wollmer, 2007, Association study of cholesterol-related genes in Alzheimer's disease, Neurogenetics, 8, 179, 10.1007/s10048-007-0087-z · DOI
- Wolozin, 2000, Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors, Arch. Neurol., 57, 1439, 10.1001/archneur.57.10.1439 · DOI · Paper page
- Woodruff-Pak, 2007, A rabbit model of Alzheimer's disease: valid at neuropathological, cognitive, and therapeutic levels, J. Alzheimer's Dis., 11, 371, 10.3233/JAD-2007-11313 · DOI
- Woodruff-Pak, 1997, Nimodipine ameliorates impaired eyeblink classical conditioning in order rabbits in the long-delay paradigm, Neurobiol. Aging, 18, 641, 10.1016/S0197-4580(97)00159-0 · DOI
- Wu, 2003, Brain region-dependent increases in β-amyloid and apolipoprotein E levels in hypercholesterolemic rabbits, J. Neural. Transm., 110, 641, 10.1007/s00702-002-0809-1 · DOI
- Xu, 1998, Relationship between abnormal cholesterol synthesis and retarded learning in rats, Metabolism, 47, 878, 10.1016/S0026-0495(98)90130-5 · DOI
- Xue, 2007, Microglial activation in the hippocampus of hypercholesterolemic rabbits occurs independent of increased amyloid production, J. Neuroinflamm., 4, 20, 10.1186/1742-2094-4-20 · DOI · Paper page
- Yaffe, 2002, Serum lipoprotein levels, statin use, and cognitive function in older women, Arch. Neurol., 59, 378, 10.1001/archneur.59.3.378 · DOI · Paper page
- Yanagisawa, 2002, Cholesterol and pathological processes in Alzheimer's disease, J. Neurosci. Res., 70, 361, 10.1002/jnr.10348 · DOI · Paper page
- Yao, 2002, Function of β-amyloid in cholesterol transport: a lead to neurotoxicity, FASEB J., 16, 1677, 10.1096/fj.02-0285fje · DOI · Paper page
- Yehuda, 1993, Modulation of learning, pain thresholds, and thermoregulation in the rat by preparations of free purified α-linolenic and linoleic acids: determination of the optimal ω3-to-ω6 ratio, Proc. Natl. Acad. Sci. U.S.A., 90, 10345, 10.1073/pnas.90.21.10345 · DOI · Paper page
- Yehuda, 1998, Modulation of learning and neuronal membrane composition in the rat by essential fatty acid preparation: time-course analysis, Neurochem. Res., 23, 627, 10.1023/A:1022430620205 · DOI
- Zandi, 2005, Do statins reduce risk of incident dementia and Alzheimer's disease?, Arch. Gen. Psychiatry, 62, 217, 10.1001/archpsyc.62.2.217 · DOI · Paper page
- Zatta, 2002, Astrocytosis, microgliosis, metallothionein-I-II and amyloid expression in high cholesterol-fed rabbits, J. Alzheimer's Dis., 4, 1, 10.3233/JAD-2002-4101 · DOI · Paper page
- Zhao, 2009, Polar metabolite of cholesterol induces rat cognitive dysfunctions, Neuroscience, 164, 398, 10.1016/j.neuroscience.2009.08.027 · DOI
- Zhou, 2008, Genetic association between low-density lipoprotein receptor-related protein gene polymorphisms and Alzheimer's disease in Chinese Han population, Neurosci. Lett., 444, 109, 10.1016/j.neulet.2008.07.093 · DOI
Cited by
Gorelick, P. B., Furie, K. L., Iadecola, C., Smith, E. E., Waddy, S. P., Lloyd-Jones, D. M., Bae, H.-J., Bauman, M. A., Dichgans, M., Duncan, P. W., et al. (2017) · Stroke · doi:10.1161/str.0000000000000148 · Cited by 411
Cholesterol: its regulation and role in central nervous system disorders
Orth, M., & Bellosta, S. (2012) · Cholesterol · doi:10.1155/2012/292598 · Cited by 339
Searcy, J. L., Phelps, J. T., Pancani, T., Kadish, I., Popovic, J., Anderson, K. L., Beckett, T. L., Murphy, M. P., Chen, K.-C., Blalock, E. M., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-111661 · Cited by 154
“Given the evidence for potentially causal associations between dyslipidemia and cognitive decline and AD [2–4, 93–96], we tested whether the effects of PIO on serum lipid levels (decreased cholesterol, HDL and triglycerides, Table 1) were correlated with improved learning.”
Can Cholesterol Metabolism Modulation Affect Brain Function and Behavior?
Cartocci, V., Servadio, M., Trezza, V., & Pallottini, V. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25488 · Cited by 77
“This association appears to change as a function of age, with cholesterol having its most detrimental effects in mid-life and its most beneficial or protective effects in the elderly (Schreurs, 2010).”
BackgroundJustice, M. J., Buchovecky, C. M., Kyle, S. M., & Djukic, A. (2013) · Rare Diseases · doi:10.4161/rdis.27265 · Cited by 61
Metadata
- Authors
- Schreurs, B. G.
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2010-07
- Volume
- 34
- Issue
- 8
- Pages
- 1366-1379
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W2055488264
- Cited by
- 105
- References
- 47
- FWCI
- 8.07
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effects of cholesterol on learning and memory. https://app.cochat.ai/papers/10.1016/j.neubiorev.2010.04.010
- The paper
- Schreurs, B. G. (2010). The effects of cholesterol on learning and memory. Neuroscience & Biobehavioral Reviews. https://doi.org/10.1016/j.neubiorev.2010.04.010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.